{"id":408523,"date":"2021-01-05T08:33:31","date_gmt":"2021-01-05T13:33:31","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=408523"},"modified":"2021-01-05T08:33:31","modified_gmt":"2021-01-05T13:33:31","slug":"biolase-to-present-at-the-h-c-wainwrights-bioconnect-2021-investor-conference","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/biolase-to-present-at-the-h-c-wainwrights-bioconnect-2021-investor-conference\/","title":{"rendered":"BIOLASE To Present At The H.C. Wainwright’s BIOCONNECT 2021 Investor Conference"},"content":{"rendered":"
\n

PR Newswire<\/p>\n<\/p><\/div>\n

\n

\n FOOTHILL RANCH, Calif.<\/span>, Jan. 5, 2021<\/span> \/PRNewswire\/ —\u00a0<\/b>BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, announced today that Todd Norbe<\/span>, President and Chief Executive Officer and John Beaver<\/span>, Chief Operating Officer and Chief Financial Officer, will be providing an overview of the Company, as well as recent progress and achievements, at the H.C. Wainwright BIOCONNECT 2021 Investor Conference, which takes place January 11-14, 2021<\/span>. A webcast of BIOLASE’s recorded company presentation will be available on-demand beginning at 6:00 a.m. ET<\/span> on January 11<\/span>th<\/sup>, and can be accessed in the investor relations section of BIOLASE’s website at\u00a0www.biolase.com<\/a>. <\/p>\n

\n

\n
\n \"BIOLASE
\n <\/a>\n <\/p>\n<\/p><\/div>\n

Management will also be available for virtual one-on-one meetings with investors during the event. To request a meeting please contact your H.C. Wainwright representative or BIOLASE’s investor relations firm at tkehrli@evcgroup.com<\/a>.\u00a0 <\/p>\n

\n About BIOLASE, Inc.<\/b>\n <\/p>\n

BIOLASE is a medical device company that develops, manufactures, markets, and sells laser systems in dentistry and medicine. \u00a0BIOLASE’s products advance the practice of dentistry and medicine for patients and healthcare professionals.\u00a0 BIOLASE’s\u00a0proprietary laser products incorporate approximately 261 patented and 52 patent-pending technologies designed to provide biologically and clinically superior performance with less pain and faster recovery times.\u00a0 BIOLASE’s\u00a0innovative products provide cutting-edge technology at competitive prices to deliver superior results for dentists and patients.\u00a0 BIOLASE’s\u00a0principal products are revolutionary dental laser systems that perform a broad range of dental procedures, including cosmetic and complex surgical applications.\u00a0 BIOLASE\u00a0has sold over 41,200 laser systems to date in over 80 countries around the world.\u00a0 Laser products under development address\u00a0BIOLASE’s\u00a0core dental market and other adjacent medical and consumer applications.<\/p>\n

For updates and information on Waterlase iPlus\u00ae, Waterlase Express\u2122, and laser dentistry, find\u00a0BIOLASE\u00a0online at\u00a0www.biolase.com<\/a>,\u00a0Facebook\u00a0at\u00a0www.facebook.com\/biolase<\/a>, Twitter at\u00a0www.twitter.com\/biolaseinc<\/a>,\u00a0Instagram at\u00a0www.instagram.com\/waterlase_laserdentistry<\/a>, and LinkedIn at\u00a0www.linkedin.com\/company\/biolase<\/a>.<\/p>\n

BIOLASE\u00ae, Waterlase\u00ae and Waterlase iPlus\u00ae are registered trademarks of\u00a0BIOLASE, Inc.<\/p>\n

\u00a0<\/p>\n

<\/div>\n

\n \"Cision\" View original content to download multimedia:http:\/\/www.prnewswire.com\/news-releases\/biolase-to-present-at-the-hc-wainwrights-bioconnect-2021-investor-conference-301200830.html<\/a><\/p>\n

SOURCE BIOLASE, Inc.<\/p>\n<\/p><\/div>\n

\"\"<\/p>\n","protected":false},"excerpt":{"rendered":"

PR Newswire FOOTHILL RANCH, Calif., Jan. 5, 2021 \/PRNewswire\/ —\u00a0BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, announced today that Todd Norbe, President and Chief Executive Officer and John Beaver, Chief Operating Officer and Chief Financial Officer, will be providing an overview of the Company, as well as recent progress and achievements, at the H.C. Wainwright BIOCONNECT 2021 Investor Conference, which takes place January 11-14, 2021. A webcast of BIOLASE’s recorded company presentation will be available on-demand beginning at 6:00 a.m. ET on January 11th, and can be accessed in the investor relations section of BIOLASE’s website at\u00a0www.biolase.com. Management will also be available for virtual one-on-one meetings with investors during the event. To request a meeting please contact … <\/p>\n

Continue reading “BIOLASE To Present At The H.C. Wainwright’s BIOCONNECT 2021 Investor Conference”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-408523","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nBIOLASE To Present At The H.C. Wainwright's BIOCONNECT 2021 Investor Conference - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/biolase-to-present-at-the-h-c-wainwrights-bioconnect-2021-investor-conference\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"BIOLASE To Present At The H.C. Wainwright's BIOCONNECT 2021 Investor Conference - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"PR Newswire FOOTHILL RANCH, Calif., Jan. 5, 2021 \/PRNewswire\/ —\u00a0BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, announced today that Todd Norbe, President and Chief Executive Officer and John Beaver, Chief Operating Officer and Chief Financial Officer, will be providing an overview of the Company, as well as recent progress and achievements, at the H.C. Wainwright BIOCONNECT 2021 Investor Conference, which takes place January 11-14, 2021. A webcast of BIOLASE’s recorded company presentation will be available on-demand beginning at 6:00 a.m. ET on January 11th, and can be accessed in the investor relations section of BIOLASE’s website at\u00a0www.biolase.com. Management will also be available for virtual one-on-one meetings with investors during the event. To request a meeting please contact … Continue reading "BIOLASE To Present At The H.C. Wainwright’s BIOCONNECT 2021 Investor Conference"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/biolase-to-present-at-the-h-c-wainwrights-bioconnect-2021-investor-conference\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-01-05T13:33:31+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mma.prnewswire.com\/media\/700996\/BIOLASE_Logo.jpg\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biolase-to-present-at-the-h-c-wainwrights-bioconnect-2021-investor-conference\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biolase-to-present-at-the-h-c-wainwrights-bioconnect-2021-investor-conference\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"BIOLASE To Present At The H.C. Wainwright’s BIOCONNECT 2021 Investor Conference\",\"datePublished\":\"2021-01-05T13:33:31+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biolase-to-present-at-the-h-c-wainwrights-bioconnect-2021-investor-conference\\\/\"},\"wordCount\":349,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biolase-to-present-at-the-h-c-wainwrights-bioconnect-2021-investor-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/700996\\\/BIOLASE_Logo.jpg\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biolase-to-present-at-the-h-c-wainwrights-bioconnect-2021-investor-conference\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biolase-to-present-at-the-h-c-wainwrights-bioconnect-2021-investor-conference\\\/\",\"name\":\"BIOLASE To Present At The H.C. Wainwright's BIOCONNECT 2021 Investor Conference - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biolase-to-present-at-the-h-c-wainwrights-bioconnect-2021-investor-conference\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biolase-to-present-at-the-h-c-wainwrights-bioconnect-2021-investor-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/700996\\\/BIOLASE_Logo.jpg\",\"datePublished\":\"2021-01-05T13:33:31+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biolase-to-present-at-the-h-c-wainwrights-bioconnect-2021-investor-conference\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biolase-to-present-at-the-h-c-wainwrights-bioconnect-2021-investor-conference\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biolase-to-present-at-the-h-c-wainwrights-bioconnect-2021-investor-conference\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/700996\\\/BIOLASE_Logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/700996\\\/BIOLASE_Logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biolase-to-present-at-the-h-c-wainwrights-bioconnect-2021-investor-conference\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"BIOLASE To Present At The H.C. Wainwright’s BIOCONNECT 2021 Investor Conference\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"BIOLASE To Present At The H.C. Wainwright's BIOCONNECT 2021 Investor Conference - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/biolase-to-present-at-the-h-c-wainwrights-bioconnect-2021-investor-conference\/","og_locale":"en_US","og_type":"article","og_title":"BIOLASE To Present At The H.C. Wainwright's BIOCONNECT 2021 Investor Conference - Market Newsdesk","og_description":"PR Newswire FOOTHILL RANCH, Calif., Jan. 5, 2021 \/PRNewswire\/ —\u00a0BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, announced today that Todd Norbe, President and Chief Executive Officer and John Beaver, Chief Operating Officer and Chief Financial Officer, will be providing an overview of the Company, as well as recent progress and achievements, at the H.C. Wainwright BIOCONNECT 2021 Investor Conference, which takes place January 11-14, 2021. A webcast of BIOLASE’s recorded company presentation will be available on-demand beginning at 6:00 a.m. ET on January 11th, and can be accessed in the investor relations section of BIOLASE’s website at\u00a0www.biolase.com. Management will also be available for virtual one-on-one meetings with investors during the event. To request a meeting please contact … Continue reading \"BIOLASE To Present At The H.C. Wainwright’s BIOCONNECT 2021 Investor Conference\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/biolase-to-present-at-the-h-c-wainwrights-bioconnect-2021-investor-conference\/","og_site_name":"Market Newsdesk","article_published_time":"2021-01-05T13:33:31+00:00","og_image":[{"url":"https:\/\/mma.prnewswire.com\/media\/700996\/BIOLASE_Logo.jpg","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biolase-to-present-at-the-h-c-wainwrights-bioconnect-2021-investor-conference\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biolase-to-present-at-the-h-c-wainwrights-bioconnect-2021-investor-conference\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"BIOLASE To Present At The H.C. Wainwright’s BIOCONNECT 2021 Investor Conference","datePublished":"2021-01-05T13:33:31+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biolase-to-present-at-the-h-c-wainwrights-bioconnect-2021-investor-conference\/"},"wordCount":349,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biolase-to-present-at-the-h-c-wainwrights-bioconnect-2021-investor-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/700996\/BIOLASE_Logo.jpg","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biolase-to-present-at-the-h-c-wainwrights-bioconnect-2021-investor-conference\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/biolase-to-present-at-the-h-c-wainwrights-bioconnect-2021-investor-conference\/","name":"BIOLASE To Present At The H.C. Wainwright's BIOCONNECT 2021 Investor Conference - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biolase-to-present-at-the-h-c-wainwrights-bioconnect-2021-investor-conference\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biolase-to-present-at-the-h-c-wainwrights-bioconnect-2021-investor-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/700996\/BIOLASE_Logo.jpg","datePublished":"2021-01-05T13:33:31+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biolase-to-present-at-the-h-c-wainwrights-bioconnect-2021-investor-conference\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/biolase-to-present-at-the-h-c-wainwrights-bioconnect-2021-investor-conference\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biolase-to-present-at-the-h-c-wainwrights-bioconnect-2021-investor-conference\/#primaryimage","url":"https:\/\/mma.prnewswire.com\/media\/700996\/BIOLASE_Logo.jpg","contentUrl":"https:\/\/mma.prnewswire.com\/media\/700996\/BIOLASE_Logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biolase-to-present-at-the-h-c-wainwrights-bioconnect-2021-investor-conference\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"BIOLASE To Present At The H.C. Wainwright’s BIOCONNECT 2021 Investor Conference"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/408523","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=408523"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/408523\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=408523"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=408523"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=408523"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}